AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22496401 — intervention group
Group type: COMPARATOR
Intervention: Usual-invitation group (started receiving food supplements at 20 weeks gestation)
Number of subjects: 180
Study 19413491 — intervention group
Group type: EXPERIMENTAL
Intervention: Older individuals (≥65 years)
Number of subjects: 0
Study 19413491 — intervention group
Group type: COMPARATOR
Intervention: Younger individuals (<65 years)
Number of subjects: 0
Study 17380562 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion Risk Score (TRS) based on clinicopathological factors including preoperative haemoglobin concentration below 12.5 g/dl, largest tumour more than 4 cm, need for exposure of the vena cava, need for an associated procedure, and cirrhosis.
Number of subjects: 480
Study 15084207 — intervention group
Group type: EXPERIMENTAL
Intervention: General population (HRV measures)
Number of subjects: 149
Study 15084207 — intervention group
Group type: EXPERIMENTAL
Intervention: General population (LF, HF, total frequency power)
Number of subjects: 149
Study 15084207 — intervention group
Group type: COMPARATOR
Intervention: AMI patients (HRV measures)
Number of subjects: 149
Study 15084207 — intervention group
Group type: COMPARATOR
Intervention: AMI patients (LF power distribution)
Number of subjects: 149
Study 12374430 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular replacement therapy using mesencephalic brain cells from fetal cadavers
Number of subjects: 0
Study 12374430 — intervention group
Group type: EXPERIMENTAL
Intervention: New methods to increase transplant survival and distribution
Number of subjects: 0
Study 12374430 — intervention group
Group type: COMPARATOR
Intervention: Neural transplantation
Number of subjects: 0
Study 9520913 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (plasma concentrations between 15-20 micrograms/ml)
Number of subjects: 24
Study 9520913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9520913 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 24
Study 7517442 — intervention group
Group type: EXPERIMENTAL
Intervention: MACOP-B
Number of subjects: 221
Study 7517442 — intervention group
Group type: COMPARATOR
Intervention: ProMACE-MOPP
Number of subjects: 221
Study 2702169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride iontophoresis (initial treatment)
Number of subjects: 0
Study 2702169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride iontophoresis (second treatment after 4 weeks)
Number of subjects: 0
Study 2702169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride iontophoresis (third application)
Number of subjects: 0
Study 2702169 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 4753234 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam administration (30 mg or less)
Number of subjects: 1
Study 4753234 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam administration (larger doses)
Number of subjects: 1
Study 4753234 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of plasma levels of diazepam and its active metabolite
Number of subjects: 1
Study 31787152 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT)
Number of subjects: 235
Study 31787152 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 235
Study 30959415 — intervention group
Group type: EXPERIMENTAL
Intervention: Small financial incentives for smoking abstinence
Number of subjects: 75
Study 28100525 — intervention group
Group type: EXPERIMENTAL
Intervention: Peres' formula (P)
Number of subjects: 188
Study 28100525 — intervention group
Group type: COMPARATOR
Intervention: Radiological landmark-based technique (R)
Number of subjects: 188
Study 26083705 — intervention group
Group type: EXPERIMENTAL
Intervention: Skiing intervention (12-week duration)
Number of subjects: 34
Study 26083705 — intervention group
Group type: COMPARATOR
Intervention: Control group (no skiing intervention)
Number of subjects: 34
Study 26083705 — intervention group
Group type: EXPERIMENTAL
Intervention: Skiing intervention
Number of subjects: 34
Study 23773310 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning bright-light therapy (10,000 lux)
Number of subjects: 60
Study 23773310 — intervention group
Group type: COMPARATOR
Intervention: Inactive light (100 lux)
Number of subjects: 60
Study 21612143 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg/Kg
Number of subjects: 120
Study 21612143 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/Kg
Number of subjects: 120
Study 21612143 — intervention group
Group type: COMPARATOR
Intervention: Ketamine 0.125 mg/Kg
Number of subjects: 120
Study 21612143 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline)
Number of subjects: 120
Study 19849639 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system (MTS)
Number of subjects: 128
Study 19849639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 16796730 — intervention group
Group type: EXPERIMENTAL
Intervention: WS 5570 600 mg/day
Number of subjects: 332
Study 16796730 — intervention group
Group type: EXPERIMENTAL
Intervention: WS 5570 1200 mg/day
Number of subjects: 332
Study 16796730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 16796730 — intervention group
Group type: EXPERIMENTAL
Intervention: WS 5570 600 mg/day and WS 5570 1200 mg/day
Number of subjects: 332
Study 16796730 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 332
Study 19777696 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose interferon-alpha (HD IFN)
Number of subjects: 0
Study 11157827 — intervention group
Group type: EXPERIMENTAL
Intervention: HMG
Number of subjects: 40
Study 11157827 — intervention group
Group type: COMPARATOR
Intervention: rhFSH
Number of subjects: 40
Study 9404441 — intervention group
Group type: EXPERIMENTAL
Intervention: Pituitary stimulation tests (GnRH and TRH injections)
Number of subjects: 47
Study 9404441 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 47
Study 9404441 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher free oestradiol index in test subjects
Number of subjects: 47
Study 8124019 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprobe at -70 degrees C
Number of subjects: 128
Study 8124019 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprobe at -82 degrees C
Number of subjects: 128
Study 3126455 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified cellulose (Hemophan)
Number of subjects: 2
Study 30563488 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Schools: Skelmersdale (AS:Sk) multi-component pilot intervention
Number of subjects: 18
Study 30563488 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom based activities
Number of subjects: 18
Study 30563488 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities outside of the classroom
Number of subjects: 18
Study 30563488 — intervention group
Group type: EXPERIMENTAL
Intervention: Various facilitators identified
Number of subjects: 18
Study 30563488 — intervention group
Group type: EXPERIMENTAL
Intervention: Various barriers identified
Number of subjects: 18
Study 27548216 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval Sprinting Exercise (ISE)
Number of subjects: 48
Study 27548216 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Tea and Interval Sprinting Exercise (GT + ISE)
Number of subjects: 48
Study 27548216 — intervention group
Group type: COMPARATOR
Intervention: Green Tea (GT)
Number of subjects: 48
Study 27548216 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 48
Study 24060588 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 174
Study 24060588 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal therapy (IPT)
Number of subjects: 174
Study 24060588 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication (ADM) alone or in combination with CT or IPT
Number of subjects: 174
Study 24060588 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (ADM + CT or IPT)
Number of subjects: 174
Study 24060588 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy group (CT or IPT)
Number of subjects: 174
Study 22327475 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI responses with two cues (binocular disparity and relative motion)
Number of subjects: 0
Study 20564094 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide (25 mg) plus dexamethasone (40 mg)
Number of subjects: 353
Study 18501073 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous 5‐FU infusion plus oxaliplatin (n = 23)
Number of subjects: 129
Study 18501073 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly 5‐FU bolus with LV plus oxaliplatin (n = 40)
Number of subjects: 129
Study 18501073 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin with 2‐day infusion 5‐FU/LV (FOLFOX4, n = 41)
Number of subjects: 129
Study 18501073 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronomodulated 5‐FU plus oxaliplatin (n = 25)
Number of subjects: 129
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum water consumption
Number of subjects: 55
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: Total water intake
Number of subjects: 55
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: Water output through urine
Number of subjects: 55
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: Total water output
Number of subjects: 55
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: Net water balance
Number of subjects: 55
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body water (TBW)
Number of subjects: 55
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-free mass (FFM)
Number of subjects: 55
Study 15941885 — intervention group
Group type: EXPERIMENTAL
Intervention: FFM hydration (TBW:FFM)
Number of subjects: 55
Study 12812689 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Education (IE)
Number of subjects: 68
Study 12812689 — intervention group
Group type: COMPARATOR
Intervention: Group Education (GE)
Number of subjects: 68
Study 10565607 — intervention group
Group type: EXPERIMENTAL
Intervention: Profound hypotension induced by enalapril and nitroglycerin for a mean duration of 71 min
Number of subjects: 21
Study 10565607 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypotension induced)
Number of subjects: 21
Study 10565607 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (hypotension and control)
Number of subjects: 21
Study 8758503 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (20 mg) taken in one intake
Number of subjects: 121
Study 8758503 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (20 mg) taken in two intakes
Number of subjects: 121
Study 8758503 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (20 mg) in both one and two intakes
Number of subjects: 121
Study 1683179 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 90
Study 1683179 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 90
Study 1683179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 1683179 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine and Ranitidine
Number of subjects: 90
Study 6110188 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydergot plus (combination of dihydroergotamine and etilefrine)
Number of subjects: 40
Study 6110188 — intervention group
Group type: COMPARATOR
Intervention: Dihydroergotamine (2 mg, 3 times daily)
Number of subjects: 40
Study 6110188 — intervention group
Group type: COMPARATOR
Intervention: Etilefrine (20 mg, 3 times daily)
Number of subjects: 40
Study 31047819 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination HAL‐SJ and occupational therapy
Number of subjects: 12
Study 31047819 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy
Number of subjects: 12
Study 29050852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sox2/Pax6 dimerization on a DNA library with randomized Pax6 half-site positions
Number of subjects: 1024
Study 29050852 — intervention group
Group type: EXPERIMENTAL
Intervention: ChIP-seq data re-analysis
Number of subjects: 1024
Study 25723140 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal ARV treatment
Number of subjects: 2333
Study 25723140 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal LNS/maternal ARV
Number of subjects: 2333
Study 25723140 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal LNS without ARVs
Number of subjects: 2333
Study 25723140 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions in infants
Number of subjects: 2333
Study 24193176 — intervention group
Group type: EXPERIMENTAL
Intervention: OSTAP block
Number of subjects: 0
Study 24193176 — intervention group
Group type: COMPARATOR
Intervention: TAP block
Number of subjects: 0
Study 24193176 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 21689773 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 54
Study 21689773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 18922516 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative clause experience
Number of subjects: 0
Study 18922516 — intervention group
Group type: COMPARATOR
Intervention: Control experience
Number of subjects: 0
Study 17499771 — intervention group
Group type: EXPERIMENTAL
Intervention: Entonox
Number of subjects: 61
Study 17499771 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 61
Study 17499771 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine gel
Number of subjects: 61
Study 15202047 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesia/sedation (group 2)
Number of subjects: 37
Study 15202047 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (group 3)
Number of subjects: 37
Study 15202047 — intervention group
Group type: COMPARATOR
Intervention: No sedation (control group 1)
Number of subjects: 37
Study 15171770 — intervention group
Group type: EXPERIMENTAL
Intervention: Microporous polysaccharide hemosphere bandage
Number of subjects: 24
Study 15171770 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 24
Study 10509038 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT)
Number of subjects: 54
Study 10509038 — intervention group
Group type: COMPARATOR
Intervention: Standard melphalan and prednisone (MP) chemotherapy
Number of subjects: 54
Study 10509038 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) in poor prognosis patients with high LI (>1.2%)
Number of subjects: 54
Study 10509038 — intervention group
Group type: COMPARATOR
Intervention: Standard melphalan and prednisone (MP) chemotherapy in poor prognosis patients with high LI (>1.2%)
Number of subjects: 54
Study 10509038 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) in poor prognosis patients with high β2-M (> 3 mg/L)
Number of subjects: 54
Study 8949385 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg/day (initial treatment)
Number of subjects: 19193
Study 8949385 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitherapy and tritherapy (if necessary)
Number of subjects: 19193
Study 8949385 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment across different geographic areas (Northern Europe vs Southern Europe)
Number of subjects: 19193
Study 8949385 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment across different genders
Number of subjects: 19193
Study 8949385 — intervention group
Group type: EXPERIMENTAL
Intervention: Time and number of antihypertensive drugs
Number of subjects: 19193
Study 1774179 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 15
Study 1774179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 7340880 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1000 mg daily)
Number of subjects: 7
Study 7340880 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1000 mg daily for 5 days)
Number of subjects: 7
Study 31640241 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (2800 IU daily)
Number of subjects: 106
Study 31640241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 29236621 — intervention group
Group type: EXPERIMENTAL
Intervention: Webnovela Mirela (online Spanish-language telenovela)
Number of subjects: 25
Study 26892413 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise (CPX) test variables
Number of subjects: 2100
Study 26892413 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak Vo2 (ml·kg(‐1)·min(‐1))
Number of subjects: 2100
Study 26892413 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise duration
Number of subjects: 2100
Study 26892413 — intervention group
Group type: EXPERIMENTAL
Intervention: %ppVo2
Number of subjects: 2100
Study 24612478 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrylic acid
Number of subjects: 80
Study 24612478 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical testosterone
Number of subjects: 80
Study 24612478 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical estrogen
Number of subjects: 80
Study 24612478 — intervention group
Group type: COMPARATOR
Intervention: K-Y jelly (placebo lubricant)
Number of subjects: 80
Study 22450017 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 g of lactose in 250 cc water
Number of subjects: 39
Study 22450017 — intervention group
Group type: COMPARATOR
Intervention: 12.5 g of maltose in 250 cc water
Number of subjects: 39
Study 21053622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100
Study 21053622 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 17400977 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (AMIO) 600 mg orally for seven days before surgery and 45 mg/hr intravenously for 48 hr postoperatively
Number of subjects: 20
Study 17400977 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (AMIO)
Number of subjects: 20
Study 17400977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16290999 — intervention group
Group type: EXPERIMENTAL
Intervention: External loop recorder (1-month duration)
Number of subjects: 100
Study 16290999 — intervention group
Group type: COMPARATOR
Intervention: Holter monitor (48-hour duration)
Number of subjects: 100
Study 16290999 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per diagnosis
Number of subjects: 100
Study 16290999 — intervention group
Group type: COMPARATOR
Intervention: Holter followed by loop recorder strategy
Number of subjects: 100
Study 16290999 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop recorder followed by Holter strategy
Number of subjects: 100
Study 16290999 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental cost-effectiveness ratio of loop recorder
Number of subjects: 100
Study 16290999 — intervention group
Group type: EXPERIMENTAL
Intervention: Bootstrapping analysis
Number of subjects: 100
Study 12015692 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertapenem (1 g once daily)
Number of subjects: 540
Study 12015692 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin-tazobactam (3.375 g every 6 h)
Number of subjects: 540
Study 9518998 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 10
Study 8556971 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (10, 20, 50 mg)
Number of subjects: 10
Study 8556971 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (20 mg)
Number of subjects: 10
Study 8556971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31537443 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine (RZV)
Number of subjects: 0
Study 31537443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30619887 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose carvedilol (3.125 mg twice daily) for 1 week
Number of subjects: 30
Study 26556616 — intervention group
Group type: EXPERIMENTAL
Intervention: Night shift
Number of subjects: 51
Study 25458027 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600mg tid
Number of subjects: 42
Study 25458027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 22471288 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrogative intention-only condition
Number of subjects: 762
Study 22471288 — intervention group
Group type: COMPARATOR
Intervention: Declarative intention-only condition
Number of subjects: 762
Study 22471288 — intervention group
Group type: COMPARATOR
Intervention: Interrogative intention + moral norm condition
Number of subjects: 762
Study 19269519 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course preoperative radiotherapy (25 Gy in five fractions; n=674)
Number of subjects: 1350
Study 19269519 — intervention group
Group type: COMPARATOR
Intervention: Selective postoperative chemoradiotherapy (45 Gy in 25 fractions with concurrent 5-fluorouracil; n=676)
Number of subjects: 1350
Study 17381256 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg)
Number of subjects: 15
Study 17381256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 15497611 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoComb
Number of subjects: 55
Study 15497611 — intervention group
Group type: COMPARATOR
Intervention: Gas compresses (control)
Number of subjects: 55
Study 11242378 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection therapy (anesthetics, steroids, or both)
Number of subjects: 21
Study 9644527 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day switch therapy with parenteral cefuroxime 750 mg for 3-5 days followed by oral cefuroxime axetil 500 mg every 12 hours
Number of subjects: 0
Study 9644527 — intervention group
Group type: COMPARATOR
Intervention: 7-day therapy with parenteral cefuroxime 750 mg every 8 hours
Number of subjects: 0
Study 8162812 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 57
Study 8162812 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 57